Advice
Not recommended for use within the NHS in Scotland.
RECOMMENDATION.
This is based on the lack of long-term data to indicate that reductions in triglyceride levels provide real benefit in terms of reducing cardiovascular events, on a lack of evidence of increased patient acceptability of the product, and lack of a pharmacoeconomic case for the drug.
Download detailed advice21KB (PDF)
Medicine details
- Medicine name:
- Omega-3-acid ethyl esters (Omacor®)
- SMC ID:
- 16/02
- Indication:
- Hypertriglyceridaemia
- Pharmaceutical company
- Solvay Healthcare Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 08 November 2002